|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/519 | |||
| A61K 31/55 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2713727 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12793812.4 |
| Europos patento paraiškos padavimo data | 2012-06-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-04-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/040733 |
| Data | 2012-06-04 |
| (87) | Numeris | WO 2012/167247 |
| Data | 2012-12-06 |
| (30) | Numeris | Data | Šalis |
| 201161493217 P | 2011-06-03 | US | |
| 201261613207 P | 2012-03-20 | US |
| (72) |
CHAKRAVARTY, Arijit, US
VINCENT, Patrick, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
Takeda Pharmaceutical Company Ltd., Oncology DDU C-1 2F 1110 26-1 Muraokahigashi 2-chome Fujisawa, Kanagawa 251-0012, JP |
| (54) | COMBINATION OF MEK INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |
| COMBINATION OF MEK INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |